Major Pharmaceuticals recall: Levothyroxine Sodium Tablets, USP, 75 mcg and 10 related products
Stage 3 of 4: Ongoing
Last action
28 Jul 2026 Class II recall, Major Pharmaceuticals: Subpotent Drug (11 lots or presentations)
api.fda.govLast synced 6 Aug 2026, 15:58 EDT
Tracker alerts
When the stage changes
[Promise copy: the email sent when this tracker's stage changes, and how to stop it. Written by the editor.]
Free. One click to unsubscribe, in every email. We do not sell or share addresses: privacy.